The Claim

BPC 157 reduces portal hypertension and restores vascular function in animal models of liver cirrhosis and vascular occlusion without altering coagulation parameters.

Source: BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

BPC 157 lowers elevated blood pressure in the liver's blood vessels and repairs damaged blood vessel function in animals with liver scarring or blocked blood vessels, without affecting blood clotting.

See the scientific wording

BPC 157 attenuates portal hypertension and reverses vascular failure in models of liver cirrhosis and vascular occlusion, suggesting a unique ability to restore blood flow and vascular function without disrupting coagulation.

Why this might work

BPC 157 fixes broken blood vessels by balancing nitric oxide levels and changing the physical structure of vessel walls within minutes, which opens new pathways for blood to flow around blockages and lowers pressure in the liver's main blood vessels without affecting blood clotting.

Verified mechanismbased on 1 study

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.